Adrianne Gladden-Young is a senior research associate in Pardis Sabeti’s lab at the Broad Institute and Harvard University where she conducts genomic studies of the viruses responsible for some of the world’s most severe and deadly infectious disease outbreaks. She is currently leading benchwork efforts to use SARS-CoV-2 genomic epidemiology as a tool to understand the spread of COVID-19 during the pandemic. And, she uses her knowledge and expertise to ensure lab safety through her role as a representative of the Broad’s Environmental Health and Safety group.
For the past 15 years, Adrianne has conducted lab research to study viruses – including HIV, Lassa, Ebola, Zika, rabies, and Hepatitis A – in response to global public health crises. She spent 1 year conducting vaccine clinical trials to measure the immunogenicity of flavivirus vaccine candidates. She also spent time working with a biotech company to evaluate a pathogen detection system prototype designed to identify biological threats found in the air, and in different sample types. And as a former member of the Massachusetts General Hospital Hazardous Materials Response Team, Adrianne is formally trained in hospital-based response to hazardous biological and chemical mass casualty events.
She has trained and mentored many students and scientists.
Adrianne earned a B.S. in biology (minored in Africana studies), and a M.S. in biotechnology specializing in biosecurity and biodefense.
Follow this link for an updated list of her publications.